![Amy Vandekop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Vandekop
Geen lopende functies
Vermogen: 3 830 $ op 31-08-2026
Profiel
Ms. Amy Vandekop, CPA, is a Chief Accounting Officer & Controller at Kalaris Therapeutics, Inc. Ms. Vandekop was previously employed as a Senior Director-Accounting & Reporting by AlloVir, Inc. and a Senior Manager-Accounting & Reporting by Lumicell, Inc. She received her undergraduate degree from the University of Massachusetts Amherst.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0% | 27-08-2026 | 948 ( 0% ) | 3 830 $ | 31-08-2026 |
Actieve functies van Amy Vandekop
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Amy Vandekop
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLOVIRPAR | Comptroller/Controller/Auditor | 01-03-2025 |
Lumicell, Inc.
 Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and markets image-guided cancer surgery solutions | Comptroller/Controller/Auditor | 01-12-2020 |
Opleiding van Amy Vandekop
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Lumicell, Inc.
Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and markets image-guided cancer surgery solutions | Electronic Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
University of Massachusetts Amherst
 University of Massachusetts Amherst Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
